Published in Dement Geriatr Cogn Dis Extra on April 30, 2013
Evaluation of Anosognosia in Alzheimer's Disease Using the Symptoms of Early Dementia-11 Questionnaire (SED-11Q). Dement Geriatr Cogn Dis Extra (2013) 0.76
Construction of standardized Arabic questionnaires for screening neurological disorders (dementia, stroke, epilepsy, movement disorders, muscle and neuromuscular junction disorders). Neuropsychiatr Dis Treat (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry (1983) 8.71
Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet (2000) 7.31
Social disengagement and incident cognitive decline in community-dwelling elderly persons. Ann Intern Med (1999) 5.39
Does this patient have dementia? JAMA (2007) 4.99
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med (1989) 4.77
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 4.55
Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol (2002) 3.70
The AD8: a brief informant interview to detect dementia. Neurology (2005) 3.65
Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry (2007) 3.44
Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry (2000) 3.05
Promising strategies for the prevention of dementia. Arch Neurol (2009) 2.14
Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatry (1999) 2.14
The value of informant versus individual's complaints of memory impairment in early dementia. Neurology (2000) 2.10
Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry (2003) 1.63
Brief screening tests for dementia. Can J Psychiatry (2002) 1.59
Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc (2002) 1.59
Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry (2005) 1.41
One-year follow-up of medication management capacity in highly functioning older adults. J Gerontol A Biol Sci Med Sci (2000) 1.32
Memory complaint, memory performance, and psychiatric diagnosis: a community study. J Geriatr Psychiatry Neurol (1993) 1.30
Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia. Arch Neurol (2007) 1.27
Medication management capacity in highly functioning community-living older adults: detection of early deficits. J Am Geriatr Soc (1999) 1.20
The Gospel Oak Study stage IV: the clinical relevance of subjective memory impairment in older people. Psychol Med (1995) 1.17
Mild cognitive impairment (MCI): a historical perspective. Int Psychogeriatr (2007) 1.15
Predictors of subjective memory in older adults. J Gerontol B Psychol Sci Soc Sci (2004) 1.14
The relationship between psychological dimensions of depressive symptoms and cognitive functioning in the elderly - the MEMO-Study. J Psychiatr Res (2006) 1.01
Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. Am J Geriatr Pharmacother (2006) 0.98
Apathy syndrome in Alzheimer's disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors. J Alzheimers Dis (2013) 0.98
Dementia with Lewy bodies. Semin Neurol (2007) 0.97
Anosognosia in Alzheimer's disease--the petrified self. Conscious Cogn (2009) 0.96
Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. Age Ageing (1993) 0.95
Reduced ability to self-administer medication is associated with assisted living placement in a continuing care retirement community. J Am Med Dir Assoc (2005) 0.94
Validity of the Medication Administration Test among older adults with and without dementia. Am J Geriatr Pharmacother (2005) 0.94
Evaluation of the mini-mental state examination's internal consistency in a community-based sample of Mexican-American and European-American elders: results from the San Antonio Longitudinal Study of Aging. J Am Geriatr Soc (2004) 0.92
Development and validation of the Observation List for early signs of Dementia (OLD). Int J Geriatr Psychiatry (2001) 0.90
Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients. Curr Alzheimer Res (2012) 0.89
Brief informant screening test for mild cognitive impairment and early Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 0.89
Do memory complaints indicate the presence of cognitive impairment? Results of a field study. Eur Arch Psychiatry Clin Neurosci (1999) 0.83
Anosognosia: patients' distress and self-awareness of deficits in Alzheimer's disease. Am J Alzheimers Dis Other Demen (2012) 0.82
A pilot program of improved methods for community-based screening for dementia. Am J Geriatr Psychiatry (2001) 0.80
Is subjective memory loss correlated with MMSE scores or dementia? J Geriatr Psychiatry Neurol (2003) 0.77
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol (2002) 3.23
Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism. J Biol Chem (2003) 1.52
Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol (2002) 1.51
A seed for Alzheimer amyloid in the brain. J Neurosci (2004) 1.45
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci (2002) 1.42
Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J Biol Chem (2006) 1.37
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition. J Neurosci (2007) 1.17
Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant. Biochem Biophys Res Commun (2004) 1.16
Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res (2005) 1.16
Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J Biol Chem (2002) 1.09
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol Dis (2009) 1.06
Progressive neurodegeneration in C. elegans model of tauopathy. Neurobiol Dis (2005) 1.00
Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia. EMBO Rep (2008) 1.00
Effects of intervention using a community-based walking program for prevention of mental decline: a randomized controlled trial. J Am Geriatr Soc (2012) 0.98
Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease. EMBO Mol Med (2012) 0.96
Pathology of clinical and preclinical Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2013) 0.96
Part of membrane-bound Abeta exists in rafts within senile plaques in Tg2576 mouse brain. Neurobiol Aging (2005) 0.95
Assembly of hereditary amyloid beta-protein variants in the presence of favorable gangliosides. FEBS Lett (2005) 0.95
Plasmodium falciparum: selenium-induced cytotoxicity to P. falciparum. Exp Parasitol (2004) 0.94
Ultrastructural localization of flotillin-1 to cholesterol-rich membrane microdomains, rafts, in rat brain tissue. Brain Res (2003) 0.93
Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging (2006) 0.92
High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain. J Cell Mol Med (2012) 0.92
The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. Proc Natl Acad Sci U S A (2002) 0.91
Gangliosides determine the amyloid pathology of Alzheimer's disease. Neuroreport (2009) 0.91
Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Neurobiol Aging (2012) 0.90
Oligomeric proteins ultrastructurally localize to cell processes, especially to axon terminals with higher density, but not to lipid rafts in Tg2576 mouse brain. Brain Res (2005) 0.90
Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology. J Neurol Sci (2010) 0.87
Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology. J Neurosci (2012) 0.87
Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Acta Neuropathol (2005) 0.86
Glial reactions and the clearance of amyloid beta protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Acta Neuropathol (2004) 0.86
Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem (2012) 0.85
Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease? Rejuvenation Res (2008) 0.85
Enhancement of splenic glucose metabolism during acute malarial infection: correlation of findings of FDG-PET imaging with pathological changes in a primate model of severe human malaria. Am J Trop Med Hyg (2006) 0.85
Antiserum against human glucose transporter 5 is highly specific for microglia among cells of the mononuclear phagocyte system. Neurosci Lett (2003) 0.83
Pleasant physical exercise program for prevention of cognitive decline in community-dwelling elderly with subjective memory complaints. Geriatr Gerontol Int (2012) 0.83
Anosognosia: patients' distress and self-awareness of deficits in Alzheimer's disease. Am J Alzheimers Dis Other Demen (2012) 0.82
Amyloid Beta annular protofibrils in cell processes and synapses accumulate with aging and Alzheimer-associated genetic modification. Int J Alzheimers Dis (2009) 0.82
SORL1 is genetically associated with neuropathologically characterized late-onset Alzheimer's disease. J Alzheimers Dis (2013) 0.82
Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. Neurobiol Aging (2002) 0.81
Abeta N-terminal-end specific antibody reduced beta-amyloid in Alzheimer-model mice. Biochem Biophys Res Commun (2004) 0.81
Cerebral metabolic reduction in severe malaria: fluorodeoxyglucose-positron emission tomography imaging in a primate model of severe human malaria with cerebral involvement. Am J Trop Med Hyg (2004) 0.81
Characterization of mutant mice that express polyglutamine in cerebellar Purkinje cells. Brain Res (2008) 0.80
CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease. Amyloid (2014) 0.80
The impact of subjective memory complaints on quality of life in community-dwelling older adults. Psychogeriatrics (2014) 0.80
Communicative competence in Alzheimer's disease: metaphor and sarcasm comprehension. Am J Alzheimers Dis Other Demen (2012) 0.79
Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse. Neurosci Lett (2009) 0.79
Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain. EMBO J (2003) 0.79
Early detection of dementia in the community under a community-based integrated care system. Geriatr Gerontol Int (2014) 0.79
Intensive rehabilitation for dementia improved cognitive function and reduced behavioral disturbance in geriatric health service facilities in Japan. Geriatr Gerontol Int (2013) 0.78
Relative preservation of the recognition of positive facial expression "happiness" in Alzheimer disease. Int Psychogeriatr (2012) 0.78
Suppression of Abeta deposition in brain by peripheral administration of Fab fragments of anti-seed antibody. Biochem Biophys Res Commun (2005) 0.78
The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice. Acta Neuropathol Commun (2013) 0.78
A figurative proverb test for dementia: rapid detection of disinhibition, excuse and confabulation, causing discommunication. Psychogeriatrics (2011) 0.77
Intervention using a community-based walking program is effective for elderly adults with depressive tendencies. J Am Geriatr Soc (2012) 0.77
Glial fibrillary tangles in diffuse neurofibrillary tangles with calcification. Acta Neuropathol (2003) 0.77
Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations. Amyloid (2013) 0.77
A randomized controlled trial of brain-activating rehabilitation for elderly participants with dementia in residential care homes. Dement Geriatr Cogn Dis Extra (2012) 0.77
Computerized visuo-spatial memory test as a supplementary screening test for dementia. Psychogeriatrics (2010) 0.76
Benefits of off-campus education for students in the health sciences: a text-mining analysis. BMC Med Educ (2012) 0.75
Yamaguchi Facial Expression-Making Task in Alzheimer's Disease: A Novel and Enjoyable Make-a-Face Game. Dement Geriatr Cogn Dis Extra (2012) 0.75
Twelve-week physical and leisure activity programme improved cognitive function in community-dwelling elderly subjects: a randomized controlled trial. Psychogeriatrics (2014) 0.75
Pitfall Intention Explanation Task with Clue Questions (Pitfall task): assessment of comprehending other people's behavioral intentions in Alzheimer's disease. Int Psychogeriatr (2012) 0.75
Tube feeding can be discontinued by taking dopamine agonists and angiotensin-converting enzyme inhibitors in the advanced stages of dementia. J Am Geriatr Soc (2010) 0.75